Intratumoral Cancer Therapies
Nov 09, 2026
Top 5 Late-Stage Intratumoral Cancer Therapies Redefining the Oncology Pipeline
Summary Intratumoral cancer therapies represent an emerging immunotherapy approach that directly targets the tumor microenvironment, enhances localized drug delivery, minimizes systemic toxicity, and potentially converts immunologically cold tumors into hot tumors responsive to immune-based treatment. Despit...
Read More...
-Agonist.png "Toll-like Receptors Agonist")
